This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The focus of this book is "chronic" epilepsy, and it is concerned with the 20% to 40% of patients with epilepsy who have recurrent seizures despite treatment with antiepileptic drugs. The topics covered in the 18 chapters include pathophysiology, prognosis, monitoring, imaging, syndromes in children, cognitive hazards, social difficulties, behavioral consequences, strategies of treatment with antiepileptic drugs, management of children, a surgical treatment, epidemiology in developing countries, and genetics. Although most of the authors are associated with well-known medical institutions in London, England, an international approach is provided by including authors from Germany, Ireland, Canada, and the United States.
Clobazam (Frizium), an antiepileptic drug not available in the United States, is discussed in three chapters. Because this drug is available in Canada and Mexico, readers in the United States who practice near the borders of these countries may want to be familiar with its use in adjunctive therapy.
Grabow JD. Chronic Epilepsy: Its Prognosis and Management. Arch Neurol. 1992;49(12):1225. doi:10.1001/archneur.1992.00530360019005
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: